StockData
Tango Therapeutics, Inc. logo

Tango Therapeutics, Inc. (TNGX) stock

TNGXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 10/30128% above fair value
$21.89−0.22 (-1.00%)

Close on Nov 18, 2026Market cap $3.69BP/E –Yield –

Tango Therapeutics market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Tango Therapeutics's market cap was $4.33B on Nov 11, 2026, against $1.22B a year earlier. Over the last 5 years it ranged from $147.59M to $4.51B, with a median of $743.95M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$4.33B+338.3%
2025Dec 31, 2025$988.48M+197.8%
2024Dec 31, 2024$331.91M-67.1%
2023Dec 29, 2023$1.01B+57.9%
2022Dec 30, 2022$638.49M-33.3%
2021Dec 31, 2021$957.73M+494.4%
2020Dec 31, 2020$161.13M–

More Tango Therapeutics figures

See a number that looks wrong?